Abstract

Innate immune responses are linked to key metabolic pathways, yet the proximal signaling events that connect these systems remain poorly understood. Here we show that phosphofructokinase 1, liver type (PFKL), a rate-limiting enzyme of glycolysis, is phosphorylated at Ser775 in macrophages following several innate stimuli. This phosphorylation increases the catalytic activity of PFKL, as shown by biochemical assays and glycolysis monitoring in cells expressing phosphorylation-defective PFKL variants. Using a genetic mouse model in which PFKL Ser775 phosphorylation cannot take place, we observe that upon activation, glycolysis in macrophages is lower than in the same cell population of wild-type animals. Consistent with their higher glycolytic activity, wild-type cells have higher levels of HIF1α and IL-1β than PfklS775A/S775A after LPS treatment. In an in vivo inflammation model, PfklS775A/S775A mice show reduced levels of MCP-1 and IL-1β. Our study thus identifies a molecular link between innate immune activation and early induction of glycolysis.

Pro-inflammatory signals trigger innate immune pathways with consequential metabolic remodeling. Here authors show that a rate-limiting enzymes of glycolysis, PFKL, is directly regulated by innate stimuli via phosphorylation at Ser775, which modification in turn influences pro-inflammatory cytokine production.

Details

Title
Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation
Author
Wang, Meiyue 1 ; Flaswinkel, Heinrich 2 ; Joshi, Abhinav 3 ; Napoli, Matteo 4   VIAFID ORCID Logo  ; Masgrau-Alsina, Sergi 4 ; Kamper, Julia M. 1   VIAFID ORCID Logo  ; Henne, Antonia 5   VIAFID ORCID Logo  ; Heinz, Alexander 5 ; Berouti, Marleen 1 ; Schmacke, Niklas A. 1   VIAFID ORCID Logo  ; Hiller, Karsten 5   VIAFID ORCID Logo  ; Kremmer, Elisabeth 2 ; Wefers, Benedikt 6   VIAFID ORCID Logo  ; Wurst, Wolfgang 6   VIAFID ORCID Logo  ; Sperandio, Markus 4   VIAFID ORCID Logo  ; Ruland, Jürgen 3   VIAFID ORCID Logo  ; Fröhlich, Thomas 1   VIAFID ORCID Logo  ; Hornung, Veit 1   VIAFID ORCID Logo 

 Ludwig-Maximilians-Universität München, Gene Center and Department of Biochemistry, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X) 
 Ludwig-Maximilians-Universität München, Faculty of Biology, Human Biology and BioImaging, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X) 
 Technische Universität München, TranslaTUM, Center of Translational Cancer Research, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966); Technische Universität München, Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966) 
 Cardiovascular Physiology and Pathophysiology, Ludwig-Maximilians-Universität München, Faculty of Medicine Biomedical Center, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X) 
 Biotechnology and Bioinformatics, Technische Universität Braunschweig, Institute for Biochemistry, Braunschweig, Germany (GRID:grid.6738.a) (ISNI:0000 0001 1090 0254) 
 Helmholtz Zentrum München, Institute of Developmental Genetics, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Technische Universität München, TUM School of Life Sciences, Freising-Weihenstephan, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966); German Center for Neurodegenerative Diseases (DZNE) site Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3) 
Pages
6438
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3086464732
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.